Report
EUR 3185.66 For Business Accounts Only

Wealth in China: Sizing the Market Opportunity; Sizing the wealth market in China and its growth potential.

Summary

Thanks to lower economic productivity, the remarkable wealth growth rates of the past few years will not be repeated in China over the forecast period. Nevertheless, strong predicted retail investments growth – led by strong mutual fund performance – will continue to see the market grow at a faster rate than in the wider region. Between 2015 and 2019 liquid assets held by affluent individuals are forecast to record a compound annual growth rate (CAGR) of 9.2%, representing a sizable opportunity for wealth managers operating in the country.

Key Findings

- At the end of 2015, of the approximately 1.05 billion adults living in China 3.5% could be considered affluent.

- Asset growth is expected to be strongest in the $10m+ asset band, which will record a CAGR of 14.1% between 2015 and 2019, compared to a CAGR of 8.8% for mass affluent individuals.

- Deposits continue to dominate China’s retail investments market, but mutual fund holdings are forecast to grow at the fastest pace over the next five years.

- Chinese high net worth (HNW) investors allocate a noteworthy proportion of their investable assets into non-traditional investments, mostly in direct property. However, this is expected to change thanks to the recent drop in property prices.

Synopsis

Wealth in China: Sizing the Market Opportunity analyzes China's wealth and retail savings and investments markets, with a focus on the HNW segment. The report is based on our proprietary datasets.

Specifically, the report:

- Sizes the affluent market (both by the number of individuals and the value of their liquid assets) using Verdict Financial’s proprietary datasets.

- Analyzes which asset classes are favored by Chinese investors and how their preferences impact the growth of the total savings and investments market.

- Examines HNW clients’ attitudes towards non-liquid investments, such as property and commodities.

- Identifies key drivers and booking centers for offshore investments.

Reasons To Buy

- Benchmark your share of the Chinese wealth market against the current market size.

- Forecast your future growth prospects using our projections for the market to 2019.

- Identify your most promising client segment by analyzing the penetration of affluent individuals in China – both at country and regional level.

- Evaluate your HNW proposition by understanding how the local tax system affects your HNW clients.

- Review your offshore strategy by learning the HNW motivations for offshore investments and their preferred booking centers.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch